Results 41 to 50 of about 1,972,524 (235)

Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib

open access: yesRMD Open, 2019
Objectives Tofacitinib is an oral JAK inhibitor for the treatment of rheumatoid arthritis (RA). We examined response to tofacitinib 5 or 10 mg two times a day in patients with seropositive vs seronegative RA.Methods Data were pooled from five Phase III ...
Peter Nash   +6 more
doaj   +1 more source

Evaluation of Anti-CCP Positive in Patients with Systemic Lupus Erythematosus Referred to Loghman Hakim Hospital between 2007-2017; A Descriptive Study

open access: yes, 2020
Background: It has been found that some patients with Systemic lupus erythematosus (SLE) may have anti-cyclic citrullinated peptide antibodies (anti-CCP), although the clinical significance of such finding is not well established.
Emam, Mohammad Mehdi   +4 more
core   +1 more source

Usefulness of anti-cyclic citrullinate peptide antibody determination in synovial fluid analysis of patients with rheumatoid arthritis

open access: yesReumatismo, 2011
Objective: To assess the role of anti-cyclic citrullinated peptide (CCP) antibody detection in synovial fluid (SF) of RA patients compared to OA patients.
G. Valesini   +4 more
doaj   +1 more source

DIAGNOSTIC VALUE OF ANTI-PEPTIDYLARGININE DEIMINASE TYPE 4 (PADI-4) AND ANTI- CITRULLINATED PEPTIDE ANTIBODIES (ACCP) IN IRAQI PATIENTS WITH RHEUMATOID ARTHRITIS [PDF]

open access: yesBasrah Journal of Surgery, 2014
This study aimed to examine the value of anti peptidylarginine deiminase (anti-PADI-4) antibody and anti-cyclic citrullinated peptide (anti-CCP) antibody among Iraqi patients with RA and to determine whether the activity and severity in RA patients are ...
Hassan J Hasony   +1 more
doaj   +1 more source

Assessment of Auto-antibodies (RF, Anti-CCP, and Anti-RA33) in Rheumatoid Arthritis Patients: Comparative study [PDF]

open access: yes, 2022
Rheumatoid arthritis is a chronic systemic autoimmune disease which is typically present in adulthood, more common in women than men and affecting e0.5- 1% of the adulth population.Many auto-antibodies could be implicated in the pathogenesis of the ...
Aldahhan, Hawraa A Ali   +3 more
core   +1 more source

Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis

open access: yesBMC Musculoskeletal Disorders, 2007
Background Anti-cyclic citrullinated peptide (anti-CCP) antibodies have been of diagnostic value in Northern European Caucasian patients with rheumatoid arthritis (RA).
Theodoridou Katerina   +4 more
doaj   +1 more source

7- DIAGNOSTIC VALUE OF ANTIBODIES TO CITRULLINE CONTAINING PEPTIDES IN PATIENTS WITH RHEUMATOID ARTHRITIS IN SOUTHERN IRAQ43 [PDF]

open access: yesBasrah Journal of Surgery, 2009
A serological study has been done in Al-Nassiriyha, southern Iraq, from December 2006 to August 2007 designed to determine the frequency of anti-cyclic citrullinated peptide antibody (anti-CCP) in a group of patients with rheumatoid arthritis for ...
THURAYA J MEZAL   +3 more
doaj   +1 more source

Independence of carbohydrate-deficient isoforms of transferrin and cyclic citrullinated peptides in rheumatoid arthritis

open access: yesRevista Brasileira de Reumatologia
Objective: The aim of this study was to assess the relationship between the two types of posttranslational modifications of proteins in RA: glycosylation on the example of carbohydrate-deficient transferrin and citrullination by means of autoantibodies ...
Monika Gudowska   +6 more
doaj   +1 more source

Correlation between ACPA levels and disease parameters in 32 anti-CCP-positive RA patients.

open access: yes, 2018
Correlation between ACPA levels and disease parameters in 32 anti-CCP-positive RA patients.
Allan Stensballe (293505)   +5 more
core   +1 more source

CCP Supplementary Materials

open access: yes, 2019
<p>Supplementary Materials for the CCP paper</p ...
CCP
core   +1 more source

Home - About - Disclaimer - Privacy